CN1242778C - Hemiplegia treating pill - Google Patents
Hemiplegia treating pill Download PDFInfo
- Publication number
- CN1242778C CN1242778C CNB2004100336894A CN200410033689A CN1242778C CN 1242778 C CN1242778 C CN 1242778C CN B2004100336894 A CNB2004100336894 A CN B2004100336894A CN 200410033689 A CN200410033689 A CN 200410033689A CN 1242778 C CN1242778 C CN 1242778C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- blood
- root
- restrains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 206010019468 Hemiplegia Diseases 0.000 title claims abstract description 7
- 239000006187 pill Substances 0.000 title description 5
- 239000003814 drug Substances 0.000 claims abstract description 29
- 208000026106 cerebrovascular disease Diseases 0.000 claims abstract description 11
- 241000522620 Scorpio Species 0.000 claims abstract description 8
- 239000009490 scorpio Substances 0.000 claims abstract description 8
- 241000489492 Arisaema Species 0.000 claims abstract description 7
- 241001489978 Eupolyphaga Species 0.000 claims abstract description 7
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 7
- 240000004371 Panax ginseng Species 0.000 claims abstract description 7
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 7
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 7
- 210000000941 bile Anatomy 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 241000271039 Agkistrodon Species 0.000 claims description 6
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 6
- 241000903946 Clematidis Species 0.000 claims description 6
- 241000131808 Scolopendra Species 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 28
- 210000004369 blood Anatomy 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 4
- 208000007536 Thrombosis Diseases 0.000 abstract description 4
- 201000005851 intracranial arteriosclerosis Diseases 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 3
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- 208000010125 myocardial infarction Diseases 0.000 abstract description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract 2
- 208000006011 Stroke Diseases 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 241000271897 Viperidae Species 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 description 6
- 241000218628 Ginkgo Species 0.000 description 5
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001364 upper extremity Anatomy 0.000 description 3
- 206010037714 Quadriplegia Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000008899 fufang danshen Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000303379 Styrax officinalis Species 0.000 description 1
- 235000001361 Styrax officinalis Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses medicine for treating cardio-cerebrovascular diseases and the sequela of apoplexy and hemiplegia. The medicine is prepared from twenty-four kinds of Chinese medicinal herb, such as notoginseng, ginkgo leaf, fleece-flower root, scorpio, cornus officinalis sieb et zucc, giant knotweed rhizome, pueraria root, coptis root, hemlock parsley, long-noded pit viper, eucommia bark, scutellaria root, centipede, eupolyphaga, red sage root, cassia twig, ramulus taxilli, achyranthes root, korean ginseng, angelica, pilose antler, saffron, clematis root and arisaema cum bile. The medicine has the functions of reducing blood-fat, dissolving thrombus, invigorating qi and blood, clearing heat, cooling blood, promoting blood circulation by removing blood stasis, dissolving stasis and freeing channels. The medicine has obviously effects on cardio-cerebrovascular diseases, such as hyperlipemia, hypertension, cerebral thrombosis, cerebral arteriosclerosis, myocardial infarction, cerebral apoplexy and hemiplegia, sequela thereof, etc. The medicine has the characteristics of short curing period, high curing rate, difficult recurrence and no toxic and side effects. The producing technical process of the present invention is simple, and the medicine has the advantages of low cost, wide curing range, short curing period, high curing rate, difficult recurrence and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of cardiovascular and cerebrovascular disease and apoplectic hemiplegia.
Background technology
Cardiovascular and cerebrovascular disease and apoplectic hemiplegia are the clinical common frequently-occurring diseases of person in middle and old age, and on treatment technology, though obtain certain curative effect, great majority are that short-term is alleviated, and cure the symptoms, not the disease at present, and the patient need take medicine all the life.Such as, Chinese patent medicine commonly used has FUFANG DANSHEN PIAN, Radix Salviae Miltiorrhizae drop pill, storax pill for treating coronary heart disease, pills for curing heart disease etc.The most price height of this class medicine, the course of treatment is long, and cure rate is low.
The object of the present invention is to provide that a kind of scope with treatment cardiovascular and cerebrovascular disease is wide, short treating period and cure rate height, the Chinese patent medicine that safety has no side effect is to remedy the deficiency of its said medicine technology.
Technical scheme
Medication preparation process of the present invention is: Radix Notoginseng 25-30 part, Folium Ginkgo 20-25 part, Radix Polygoni Multiflori 25-30 part, Fructus Corni 8-15 part, Rhizoma Polygoni Cuspidati 10-15 part, Scorpio 10-15 part, Radix Puerariae 5-10 part, Rhizoma Coptidis 1-3 part, Rhizoma Chuanxiong 5-10 part, Agkistrodon 8-15 part, Cortex Eucommiae 3-8 part, Radix Scutellariae 7-12 part, Scolopendra 8-15 part, eupolyphaga 7-10 part, Radix Salviae Miltiorrhizae 8-15 part, Ramulus Cinnamomi 1-3 part, Herba Taxilli 3-8 part, Radix Achyranthis Bidentatae 5-10 part, Korean Ginseng 1-5 part, Radix Angelicae Sinensis 8-15 part, Cornu Cervi Pantotrichum 3-6 part, Stigma Croci 2-7 part, Radix Clematidis 10-15 part, Arisaema Cum Bile 3-6 part, 20 four Chinese medicines are got the raw materials ready by the prescription proportioning, pulverized 100-150 order fine powder, fully behind the mix homogeneously, behind the medicated powder disinfection by ultraviolet light, incapsulate by every capsule 0.5 gram, get patent medicine.
Solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's traditional medicine to the cardiovascular diseases, with reference to the modern pharmacological research achievement, according to clinical experience for many years, control " blood stasis dispelling is not forgotten in Zhitan, blood stasis dispelling palpus blood fat reducing earlier; benefiting vital QI and blood; liver-kidney tonifying, blood circulation promoting and blood stasis dispelling, activating qi and collateral " to debate to execute.
On pharmacology: Radix Notoginseng, Radix Salviae Miltiorrhizae energy promoting the circulation of blood hemostasis collateral dredging; The Folium Ginkgo benefit motive, astringe the lung; Radix Polygoni Multiflori invigorating the liver and kidney, tonifying YIN blood; The Scorpio calming wind and dredging collateral; Vital essence is mended in the Fructus Corni the kidney invigorating; Rhizoma Polygoni Cuspidati expelling wind and removing dampness dissipating blood stasis to promote menstruationg; Rhizoma Chuanxiong sector-style dissipating depression of QI is searched irritability and is enriched blood; The Rhizoma Coptidis clearing away heat and cooling blood, pathogenic fire purging dampness, benefiting vital QI and blood, blood circulation promoting and blood stasis dispelling, activating qi and collateral are evacuated thrombosis, blood vessels are without hindrance, Trombin inhibiting combines with platelet, and the activation fibrinolytic system makes the blood dissolves smoothness of solidifying, blood fat reducing is also fallen whole blood viscosity, in case cerebral arteriosclerosis, Antilpemic and thrombolytic can be prevented controlling dual function.
The Agkistrodon dispelling wind and removing obstruction in the collateral; Scorpio, Scolopendra, eupolyphaga calming wind and dredging collateral, active, expel wind to dredge collateral; Korean Ginseng, Radix Scutellariae strongly invigorating primordial QI, invigorating middle warmer will and spirit; Herba Taxilli, the Cortex Eucommiae, Radix Achyranthis Bidentatae invigorating the liver and kidney, the liver benefiting blood, strong waist knee joint strengthening bone and muscle; Chinese angelica blood supplementing is invigorated blood circulation; Radix Salviae Miltiorrhizae, Stigma Croci blood circulation promoting and blood stasis dispelling; The Cornu Cervi Pantotrichum kidney-Yang invigorating fills blood, beneficial marrow, bone and muscle strengthening; Radix Clematidis wind-damp dispelling, the meridian dredging; The Arisaema Cum Bile expectorant that relieves inflammation or internal heat.
More than two groups of medicines share and have blood circulation promoting and blood stasis dispelling, both reduced the effect of triglyceride and cholesterol in the blood; The energy microcirculation improvement; Can promote the discharge of sub-thread, increase coronary blood flow, make blood fat and blood pressure stable; Can improve hemorheology, liptinite inner blood viscosity balance; Can real fibrin stable, the accumulation thrombosis of lysed blood makes obstructed unobstructed blood vessel, effectively controls thrombosis, can blood fat reducing, again can Zhitan, and dual curative effect is arranged.
Diseases and caused such as curable substance hyperlipidemia of the present invention, hypertension, cerebral thrombosis, cerebral infarction, cerebral arteriosclerosis, myocardial infarction: headache and dizzy, blurred vision, numb hand and foot, quadriplegia, coronary heart disease, angina pectoris, the nervous symptoms such as chest pain, palpitation and insomnia of breathing hard, feel oppressed.
The present invention can be made into any regular dosage form.For example, can be made into capsule.Adult's dose is generally every day three times, each four.
Embodiment one
Press following prescription weighting raw materials: Radix Notoginseng 25-30 gram, Folium Ginkgo 20-25 gram, Radix Polygoni Multiflori 25-30 gram, Fructus Corni 8-15 gram, Rhizoma Polygoni Cuspidati 10-15 gram, Scorpio 10-15 gram, Radix Puerariae 5-10 gram, Rhizoma Coptidis 1-3 gram, Rhizoma Chuanxiong 5-10 gram, Agkistrodon 8-15 gram, Cortex Eucommiae 3-8 gram, Radix Scutellariae 7-12 gram, Scolopendra 8-15 gram, eupolyphaga 7-10 gram, Radix Salviae Miltiorrhizae 8-15 gram, Ramulus Cinnamomi 1-3 gram, Herba Taxilli 3-8 gram, Radix Achyranthis Bidentatae 5-10 gram, Korean Ginseng 1-5 gram, Radix Angelicae Sinensis 8-15 gram, Cornu Cervi Pantotrichum 3-6 gram, Stigma Croci 2-7 gram, Radix Clematidis 10-15 gram, Arisaema Cum Bile 3-6 gram.To pulverize behind the said medicine uniform mixing, cross the 100-150 mesh sieve after, behind the medicated powder disinfection by ultraviolet light, incapsulate by every capsule 0.5 gram and to get final product.
Embodiment two
Press following prescription weighting raw materials: Radix Notoginseng 25 restrains, Folium Ginkgo 20 restrains, Radix Polygoni Multiflori 25 restrains, Fructus Corni 8 restrains, Rhizoma Polygoni Cuspidati 10 restrains, Scorpio 10 restrains, Radix Puerariae 5 restrains, Rhizoma Coptidis 1 restrains, Rhizoma Chuanxiong 5 restrains, Agkistrodon 8 restrains, the Cortex Eucommiae 3 restrains, Radix Scutellariae 7 restrains, Scolopendra 8 restrains, eupolyphaga 7 restrains, Radix Salviae Miltiorrhizae 8 restrains, Ramulus Cinnamomi 1 restrains, Herba Taxilli 3 restrains, Radix Achyranthis Bidentatae 5 restrains, Korean Ginseng 1 restrains, Radix Angelicae Sinensis 8 restrains, Cornu Cervi Pantotrichum 3 restrains, Stigma Croci 2 restrains, Radix Clematidis 10 restrains, Arisaema Cum Bile 3 restrains.To pulverize behind the said medicine uniform mixing, cross the 100-150 mesh sieve after, behind the medicated powder disinfection by ultraviolet light, incapsulate by every capsule 0.5 gram and to get final product.
Embodiment three
Press following prescription weighting raw materials: Radix Notoginseng 30 restrains, Folium Ginkgo 25 restrains, Radix Polygoni Multiflori 30 restrains, Fructus Corni 15 restrains, Rhizoma Polygoni Cuspidati 15 restrains, Scorpio 15 restrains, Radix Puerariae 10 restrains, Rhizoma Coptidis 3 restrains, Rhizoma Chuanxiong 10 restrains, Agkistrodon 15 restrains, the Cortex Eucommiae 8 restrains, Radix Scutellariae 12 restrains, Scolopendra 15 restrains, eupolyphaga 10 restrains, Radix Salviae Miltiorrhizae 15 restrains, Ramulus Cinnamomi 3 restrains, Herba Taxilli 8 restrains, Radix Achyranthis Bidentatae 10 restrains, Korean Ginseng 5 restrains, Radix Angelicae Sinensis 15 restrains, Cornu Cervi Pantotrichum 6 restrains, Stigma Croci 7 restrains, Radix Clematidis 15 restrains, Arisaema Cum Bile 6 restrains.To pulverize behind the said medicine uniform mixing, cross the 100-150 mesh sieve after, behind the medicated powder disinfection by ultraviolet light, incapsulate by every capsule 0.5 gram and to get final product.
Obtained better curative effect in the practical application.100 routine patients are observed treatment, 90% diagnostic criteria that meets China's cerebrovascular is arranged, in various degree hypertension, hyperlipidemia and cerebral infarction sequela (quadriplegia and language function obstacle) are all arranged, after taking medicine 10-15 of the present invention days, obviously take effect, blood pressure reduces, and upper limb has grip, the lower limb gram is held up and is abducted the road, and it is obviously clear to enunciate.After taking a course of treatment, effect is obviously progressive, and blood pressure is normal, and limbs can be participated in exercise, speak and also recover.Serve on three courses of treatment, strengthen consolidating, its disease is no longer recurred.Clinical results: cure rate reaches 80%, and effective percentage reaches 95%.
Case one: patient Wang: man, 56 years old, suffer from hypertension, hyperlipidemia, cerebral arteriosclerosis for many years, it is surplus to form cerebral infarction sequela 2 years, the right side limb activity is bad, 200/110 millimeter thick stick post of blood pressure, the upper limb grip is poor, dizziness, blurred vision, other medicines such as clothes coronary disease Soviet Union and ball are not all obtained ideal effect, this obeys medicine of the present invention, observes dizziness ten days, blurred vision obviously alleviates, serve on a course of treatment (28 days), one after each meal, subjective symptoms disappears, the upper limb grip, the basic recovery, three courses of treatment of logotype, all transference cures, and can be alone people go to participate in exercise and observe and do not see recurrence so far.
Case two: patient Zhao: the woman, 52 years old, 170/90 millimeter thick stick post of blood pressure, arrhythmia, heart rate 89 times/minute, nervous uncomfortable in chest, the cardiopalmus spontaneous perspiration, giddy, CT shows cerebral infarction, through hospitalization, does not see produce effects, once pays brave pills for curing heart disease, no obvious curative effects such as FUFANG DANSHEN PIAN.After course of treatment, nervous uncomfortable in chest, giddy obviously alleviates, and shows heart rate stabilization through survey two courses of treatment of logotype power (56 days) through clothes medicine of the present invention, and it is normal that blood pressure recovers, and observes and do not see recurrence so far.
Claims (2)
1, a kind of medicine for the treatment of cardiovascular and cerebrovascular disease and apoplectic hemiplegia sequela, the active ingredient of this medicine is made up of following crude drug: Radix Notoginseng 25-30 part, Folium Ginkgo 20-25 part, Radix Polygoni Multiflori 25-30 part, Fructus Corni 8-15 part, Rhizoma Polygoni Cuspidati 10-15 part, Scorpio 10-15 part, Radix Puerariae 5-10 part, Rhizoma Coptidis 1-3 part, Rhizoma Chuanxiong 5-10 part, Agkistrodon 8-15 part, Cortex Eucommiae 3-8 part, Radix Scutellariae 7-12 part, Scolopendra 8-15 part, eupolyphaga 7-10 part, Radix Salviae Miltiorrhizae 8-15 part, Ramulus Cinnamomi 1-3 part, Herba Taxilli 3-8 part, Radix Achyranthis Bidentatae 5-10 part, Korean Ginseng 1-5 part, Radix Angelicae Sinensis 8-15 part, Cornu Cervi Pantotrichum 3-6 part, Stigma Croci 2-7 part, Radix Clematidis 10-15 part, Arisaema Cum Bile 3-6 part.
2, the preparation method of the described medicine of claim 1 is characterized in that: after described crude drug was taken by weighing in proportion, uniform mixing was pulverized, and behind the 100-150 mesh sieve, behind the medicated powder disinfection by ultraviolet light, incapsulated by every capsule 0.5 gram, promptly excessively.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100336894A CN1242778C (en) | 2004-04-16 | 2004-04-16 | Hemiplegia treating pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100336894A CN1242778C (en) | 2004-04-16 | 2004-04-16 | Hemiplegia treating pill |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1593566A CN1593566A (en) | 2005-03-16 |
| CN1242778C true CN1242778C (en) | 2006-02-22 |
Family
ID=34664186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100336894A Expired - Lifetime CN1242778C (en) | 2004-04-16 | 2004-04-16 | Hemiplegia treating pill |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1242778C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101837060B (en) * | 2010-06-04 | 2011-10-05 | 王丽坤 | Chinese medicine for adjusting hypertension, hyperlipidemia and hyperglycemia |
| CN103446452A (en) * | 2012-05-30 | 2013-12-18 | 郑觉强 | Capsule for curing hypertension, hyperglycemia and hyperlipidemia |
| CN103156987B (en) * | 2013-04-07 | 2014-11-12 | 贵州鸿德中药开发有限公司 | Miao medicine for reducing blood pressure |
| CN103656518B (en) * | 2013-12-15 | 2016-01-20 | 丁飞 | For preventing the Chinese medicine composition of hip replacement deep vein thrombosis of lower extremity |
| CN103784886A (en) * | 2014-02-20 | 2014-05-14 | 柳晖 | Traditional Chinese medicine composition for treating palpitation |
| CN104013832A (en) * | 2014-06-05 | 2014-09-03 | 湖州康企药业有限公司 | Medicine for treating hemiplegia |
| CN106554889A (en) * | 2015-09-25 | 2017-04-05 | 哈尔滨华藻生物科技开发有限公司 | A kind of spirulina cholesterol reducing medicated wine and preparation method thereof |
-
2004
- 2004-04-16 CN CNB2004100336894A patent/CN1242778C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1593566A (en) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101637585B (en) | Chinese herbal preparation for treating posirasis and preparation method thereof | |
| CN1079253C (en) | Medicinal oil for dredging channels and collaterals of heart and brain and its preparing process | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN112843207A (en) | Formula and preparation method of smearing type thermal moxibustion ointment | |
| CN103127326A (en) | Pharmaceutical composition for treating osteoarthritis and preparation method thereof | |
| CN1242778C (en) | Hemiplegia treating pill | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN1814139A (en) | Baidianling capsule | |
| CN102198228A (en) | Chinese medicinal preparation for treating hypertension | |
| CN102100873B (en) | Chinese patent medicine for treating heart cerebrovascular diseases and preparation method thereof | |
| CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
| CN101711837A (en) | Traditional Chinese medicine preparation for treating coronary heart diseases and angina pectoris | |
| CN100490879C (en) | Ready-made Chinese medicine jelly-pills for treating hypertension and its preparation method | |
| CN1654066A (en) | Kidney-nourishing yang-strengthening medicine | |
| CN101700364B (en) | Thrombolytic and lipid-lowering pill | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN100484542C (en) | Chinese medicinal compound recipe for treating osteoporosis and its preparing process | |
| CN104857441A (en) | Oral preparation for treating femoral head necrosis and preparation method of oral preparation | |
| CN101716296A (en) | Traditional Chinese medicine pill for treating psoriasis | |
| CN101095894A (en) | Chinese traditional medicine composition for treating myocardium disease and method of making the same | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN1371728A (en) | Powder medicine for promoting blood circulation and removing blood stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Ma Xiaoyan Document name: Notification to Pay the Fees |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20060222 |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Di Shusheng Document name: Notice of Termination of Patent Rights |